Lacticaseibacillus paracasei KW3110
Lacticaseibacillus paracasei KW3110 is a lactic acid bacterium studied in the context of immune regulation and inflammatory processes. Research includes randomized controlled trials in humans examining seasonal allergic rhinitis symptoms and ocular disorders, as well as in vitro studies on immune cell signaling and toll-like receptor activation. Animal studies have investigated mechanisms including IL-12 production, retinal inflammation, and age-related cellular changes. Both heat-killed and viable formulations have been studied in human and preclinical models. These are research topics, not findings; the papers do not establish that this strain treats or prevents any condition.
Where it's been studied Tags come from a conservative keyword scan of each paper's title, abstract, and summary. A tag is research coverage, not measured effect. How we classify this →
Share of this strain's 21 body-system-tagged papers that concern each system. Research coverage, not measured effect.
Symptoms in the research A tag means the paper's text names the symptom or condition — research coverage, not evidence of benefit. How we classify this →
Share of this strain's 6 symptom-tagged papers that mention each symptom or condition. Research coverage, not evidence of benefit.
Research Study-type filters use AI-classified labels, audited but not guaranteed — check the paper itself before leaning on one. How we classify this →
22 papers reference this strain in the probiotic database.
Discussion
Be the first to comment.
Sign in to join the discussion.
Citations
Selected papers that name this strain.
-
[1]
Source →Table 1_Effect of heat-killed Lacticaseibacillus paracasei KW3110 on mild to moderate seasonal allergic rhinitis symptoms in Japanese adults: a randomized, double-blind, placebo-controlled parallel-group study.docx· Figshare · 2025
-
[2]
PMID 32708511 →Lactobacillus paracasei KW3110 Suppresses Inflammatory Stress-Induced Premature Cellular Senescence of Human Retinal Pigment Epithelium Cells and Reduces Ocular Disorders in Healthy Humans· International Journal of Molecular Sciences · 2020